McCormick & Company rated 'Buy' on strong brands, merger growth, and 4% dividend yield at low valuations.

McCormick & Company (MKC) is rated as a 'Buy' due to its resilient brand portfolio, expected margin expansion, and an attractive 4% dividend yield amid depressed stock valuations. The company’s planned $45 billion merger with Unilever's food business is projected to drive 3–5% revenue growth and generate $600 million in annual synergies. Despite some short-term volume challenges, MKC’s pricing power and alignment with health trends support sustainable growth and improving operating margins. With a forward price-to-earnings ratio of 15.4 and expected annual earnings growth of 8–10%, MKC is positioned for strong total returns as its valuation normalizes.